Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geospatial analysis of land use land cover patterns and floristic diversity across urban habitats in Central Himachal Pradesh, North Western Himalaya, India.

Environmental monitoring and assessment·2026
Same author

Role of diffusion weighted imaging, apparent diffusion coefficient and magnetic resonence perfusion among acute ischemic stroke patient.

Bioinformation·2026
Same author

The MRI Spectrum of Gynecological Pelvic Masses.

Cureus·2026
Same author

Risk assessment of uranium in groundwater surrounding the Greater Noida industrial area, Uttar Pradesh, India.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author

Efficacy of Microvascular Couplers for Venous Micro-anastomosis in the Reconstruction of Oral Defects.

Journal of maxillofacial and oral surgery·2025
Same author

Osteochondroma of the condyle of the mandible: A case report.

National journal of maxillofacial surgery·2025

Related Experiment Video

Updated: May 11, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

19.2K

Microinvasive oral squamous cell carcinoma: A management protocol.

Uma Shanker Pal1, Seema Devi2, Meleti Venkata Sowmya1

  • 1Department of Oral and Maxillofacial Surgery, King George's Medical University, Lucknow, Uttar Pradesh, India.

National Journal of Maxillofacial Surgery
|January 20, 2025
PubMed
Summary

Microinvasive oral squamous cell carcinoma (MISCC) management requires careful consideration of diagnostic errors and prognostic outcomes. Early detection and precise management of potentially malignant disorders are crucial for preventing cancer transformation.

Keywords:
Carcinomadiagnostic errorsinvasivenessneck dissectionneoplasmsquamous cell of head and neck

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

3.7K

Related Experiment Videos

Last Updated: May 11, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

19.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

3.7K

Area of Science:

  • Oncology
  • Oral Pathology

Background:

  • Microinvasive oral squamous cell carcinoma (MISCC) is an early-stage oral cancer characterized by basement membrane breach and invasion depth up to 2mm.
  • Oral potentially malignant disorders (OPMDs) are precursors to oral cancer, necessitating vigilant monitoring.

Purpose of the Study:

  • To formulate a management protocol for MISCC.
  • To assess the association between OPMDs and MISCC.

Main Methods:

  • A comprehensive electronic and manual literature search was performed.
  • 14 relevant articles were selected and evaluated based on inclusion/exclusion criteria.
  • Data from selected articles were tabulated for analysis.

Main Results:

  • An association between OPMDs and MISCC was observed in 12 out of 14 reviewed articles.
  • Despite NCCN guidelines, 3 out of 14 MISCC cases showed lymph node metastasis.
  • Recurrence and second primary tumors are significant concerns in MISCC management.

Conclusions:

  • A management protocol for MISCC was developed, integrating histopathological, clinical, and radiological findings.
  • Rigorous 3-year follow-up for OPMDs is recommended to prevent malignant transformation.
  • A 4-8 year follow-up is advised for MISCC patients.